avigate: Randomised controlled trial of an online treatment decision aid for men with localised prostate cancer and their partners

Swinburne University of Technology0 个研究点目标入组 304 人开始时间: 2016年12月2日最近更新: 2021年2月22日

适应症

试验速览

暂无简介。

•Patients are eligible to participate in this trial if they are aged 18 years or over, have been diagnosed with LPC in the last three months, have been deemed eligible for AS by their treating clinician or meet the NCCN guidelines for AS*, have access to the Internet and have sufficient proficiency in English to complete study requirements and use the intervention website
•*NCCN Guidelines: AS Guidelines for Clinicians:
•PSA of 20 ng/mL or less
•clinical stage T1–2
•Gleason score 6
•In some circumstances men with the following clinical characteristics may also be offered AS:
•PSA of 10 ng/mL or less
•clinical stage T1–2a
•Gleason score = (3 plus 4 equals 7) when pattern 4 component accounts for less than 10% after pathological review.
•Partners are eligible to participate in this trial if they are aged 18 or over, are the designated partner (identified by patient) of an eligible patient (see above) who has consented to take part in the trial, have access to the internet and have sufficient proficiency in English to complete study requirements and use the intervention website

•Patients are ineligible if they currently have a severe psychiatric or cognitive disorder and/or are too unwell to participate as deemed by their treating doctor, or by self-report, or by the research team at consent
•Partners are ineligible if they are not able to provide informed consent as determined by the research team

发起方